ANGELA GUERRERO: Open Payments
NPI 1811504160 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,050 in 44 payments from 14 companies in 2025. Trend: 2023 $175 · 2024 $970 · 2025 $1,050
Food & beverage: $1,050
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $222 |
| Lundbeck LLC | 7 | $168 |
| Tanabe Pharma America, Inc. | 6 | $154 |
| Janssen Biotech, Inc. | 3 | $120 |
| ARGENX US, INC. | 3 | $74 |
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
| ACADIA Pharmaceuticals Inc | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| LivaNova USA, Inc. | 1 | $35 |
| UCB, Inc. | 1 | $35 |
Products named: VYEPTI, REXULTI, QULIPTA, Radicava, UBRELVY, VYVGART, NUPLAZID, BOTOX.
Industry payments across TX — which companies pay providers there.
